Educational content only. Sequence & Signal sells nothing and does not provide medical advice. Talk to a licensed clinician about anything that concerns your health.

The Library

Briefs, filed and sourced.

Every brief is a reading guide to a body of evidence or a set of documents. Each one names its sources, states what the record establishes, and marks where it stops. None of them contains dosing, protocols, product comparisons, or sourcing information, and none ever will.

Filed under: Trial Literacy · Regulation · Analytical Chemistry · History · Terminology

Analytical chemistry instrumentation on a laboratory bench, with sample trays and a control panel.
Analytical Chemistry

How to read a certificate of analysis

A purity percentage answers one narrow question. Identity, sterility, and endotoxin content are three others, tested by different methods — and a document can look official while establishing almost nothing.

·

Printed data tables and charts spread across a desk beside a notebook.
Trial Literacy

GLP-1 receptor agonists: what the trials actually measured

The cardiovascular and weight-outcome programmes were large, long, and precise about their endpoints. Reading them well means separating what was measured from what was later claimed about it.

·

A stack of academic books and printed papers beside a pair of reading glasses.
Trial Literacy

Reading a preprint without getting fooled

Preprints are a legitimate and useful part of the record. They are also unreviewed, sometimes revised beyond recognition, and occasionally withdrawn — and none of that is visible in a screenshot.

· In edit

How to use the library

Three buckets, every time

Whenever a brief names a compound or a compound class, it says which of three categories applies. We repeat the categories rather than assuming the reader remembers them, because the distinction is where most misreadings begin.

Classification we apply

Approved
An FDA-approved drug product with a specific approved indication, an approved label, and a manufacturer subject to inspection.
In trials
A compound currently under study in registered human clinical trials. Being in trials means a question is open, not that an answer exists.
Neither
A compound with no approval and no completed human trials supporting any therapeutic claim. Preclinical or animal data, where it exists, does not change this classification.

Briefs marked In edit are drafted and in fact-checking. We publish when checking is finished, not on a schedule.

The Weekly Read

Know when a brief lands.

Thursday mornings, a short annotated list of what published this week — and a note when something new appears in the library.

We store your address to send the newsletter and nothing else. See our privacy policy.